Contact

Get in touch with Unguard Therapeutics
We welcome inquiries from partners, investors, and collaborators.

Investment highlights

  • First-in-class mechanism targeting uracil excision
  • Strong IP strategy and patent filings
  • Backed by Institut Curie discoveries
  • Addressing a major unmet need (PARPi resistance)
  • Multi-billion € market potential

Market opportunity

HRD cancers represent a significant
and growing market across multiple indications:

  • Ovarian cancer
  • Breast cancer
  • Prostate cancer
  • Pancreatic cancer

Get in touch with
Unguard Therapeutics

We welcome inquiries from partners, investors, and collaborators.

General inquiries: contact@unguardtx.com

Business / partnering: bd@unguardtx.com

Investors relations: investors@unguardtx.com